Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Ogden

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
European Journal of Pharmacology|September 24, 1999
Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neuronsD Bleakman, A M Ogden, P L Ornstein, et al.
Current Pharmaceutical Design|April 12, 2002
Kainate receptor agonists, antagonists and allosteric modulatorsD Bleakman, M R Gates, A M Ogden, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degenerationM W Dudley, B W Siegel, A M Ogden, et al.
Journal of Medicinal Chemistry|August 21, 1992
Conformationally restrained, chiral (phenylisopropyl)amino-substituted pyrazolo[3,4-d]pyrimidines and purines with selectivity for adenosine A1 and A2 receptorsN P Peet, N L Lentz, S Sunder, et al.
Journal of Neurochemistry|May 9, 2000
Inflammatory cytokines enhance muscarinic-mediated arachidonic acid release through p38 mitogen-activated protein kinase in A2058 cellsM W Wood, J A Segal, R J Mark, et al.
European Journal of Pharmacology|September 13, 1988
Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetineB M Baron, A M Ogden, B W Siegel, et al.
Journal of Medicinal Chemistry|December 10, 1993
Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonistsN P Peet, N L Lentz, M W Dudley, et al.
Neuropharmacology|March 23, 2004
Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitroA Alt, B Weiss, A M Ogden, et al.
Neuropharmacology|December 16, 1998
LY339434, a GluR5 kainate receptor agonistB Small, J Thomas, M Kemp, et al.
British Journal of Pharmacology|August 1, 1992
MDL 27,531 selectively reverses strychnine-induced seizures in miceJ H Kehne, J M Kane, F P Miller, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
European Journal of Pharmacology|September 24, 1999
Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neuronsD Bleakman, A M Ogden, P L Ornstein, et al.
Current Pharmaceutical Design|April 12, 2002
Kainate receptor agonists, antagonists and allosteric modulatorsD Bleakman, M R Gates, A M Ogden, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degenerationM W Dudley, B W Siegel, A M Ogden, et al.
Journal of Medicinal Chemistry|August 21, 1992
Conformationally restrained, chiral (phenylisopropyl)amino-substituted pyrazolo[3,4-d]pyrimidines and purines with selectivity for adenosine A1 and A2 receptorsN P Peet, N L Lentz, S Sunder, et al.
Journal of Neurochemistry|May 9, 2000
Inflammatory cytokines enhance muscarinic-mediated arachidonic acid release through p38 mitogen-activated protein kinase in A2058 cellsM W Wood, J A Segal, R J Mark, et al.
European Journal of Pharmacology|September 13, 1988
Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetineB M Baron, A M Ogden, B W Siegel, et al.
Journal of Medicinal Chemistry|December 10, 1993
Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonistsN P Peet, N L Lentz, M W Dudley, et al.
Neuropharmacology|March 23, 2004
Pharmacological characterization of glutamatergic agonists and antagonists at recombinant human homomeric and heteromeric kainate receptors in vitroA Alt, B Weiss, A M Ogden, et al.
Neuropharmacology|December 16, 1998
LY339434, a GluR5 kainate receptor agonistB Small, J Thomas, M Kemp, et al.
British Journal of Pharmacology|August 1, 1992
MDL 27,531 selectively reverses strychnine-induced seizures in miceJ H Kehne, J M Kane, F P Miller, et al.
Pageof 2